Renal Cell Carcinoma: From Diagnosis to Identification of Novel Therapeutic Targets and Minimally Invasive Treatments
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 August 2022) | Viewed by 5369
Special Issue Editors
Interests: cancer cells; cancer biology; prostate cancer; urology; prostate; bladder cancer; urologic oncology; cancer metastasis; oncology; doppler ultrasonography
Special Issues, Collections and Topics in MDPI journals
Unit of Oncologic Minimally- Invasive Urology and Andrology, Careggi Hospital, Florence, Italy
Interests: renal cell carcinoma; prostate cancer; bladder cancer; robotic surgery; biomarkers
Special Issues, Collections and Topics in MDPI journals
Interests: kidney cancer; minimally invasive surgery; reconstructive urology; surgical innovation
Special Issues, Collections and Topics in MDPI journals
Interests: renal cell carcinoma; prostate cancer; bladder cancer
Special Issues, Collections and Topics in MDPI journals
Interests: kidney cancer; prostate cancer; kidney transplantation; metabolomics
Special Issues, Collections and Topics in MDPI journals
Interests: renal cell carcinoma; prostate cancer; bladder cancer
Special Issues, Collections and Topics in MDPI journals
Interests: renal cell carcinoma; prostate cancer; bladder cancer
Special Issues, Collections and Topics in MDPI journals
Interests: renal cell carcinoma; prostate cancer; bladder cancer; robotic surgery
Special Issues, Collections and Topics in MDPI journals
2. Department of Oncology and Haematology-Oncology, Università degli studi di Milano, Milan, Italy
Interests: renal cell carcinoma; prostate cancer; bladder cancer; robotic surgery
Special Issues, Collections and Topics in MDPI journals
2. Department of Oncology and Haematology-Oncology, Università degli studi di Milano, Milan, Italy
Interests: renal cell carcinoma; prostate cancer; bladder cancer; robotic surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Renal cell carcinoma (RCC) is the most frequent malignancy affecting the adult kidney and the twelfth most common cancer. The pathophysiology of RCC is complex and arises from a combination of gene mutations (i.e., VHL, PBMR1, SETD2, BAP1, etc.) in addition to other factors such as diabetes, obesity, smoking, and hypertension. In the early stages, the disease is frequently asymptomatic and incidentally diagnosed by imaging, having a good prognosis; conversely, RCC has a high mortality rate in advanced phases, due to poor responses to radiotherapy and chemotherapy. The progressive introduction of high-throughput technologies and recent studies of molecular and genomic profiling have shed new light on the pathophysiology of RCC. Moreover, in recent years, there has been a growing interest in identifying tumor markers not only for diagnostic purposes but also to improve the predictive power of clinical and pathological parameters. This Special Issue of Diagnostics aims to collect studies on minimally invasive treatment and translational research for the management and diagnosis of renal cell carcinoma (RCC).
You may choose our Joint Special Issue in Biomedicines.
Dr. Matteo Ferro
Prof. Dr. Andrea Minervini
Prof. Dr. Alessandro Antonelli
Dr. Angelo Porreca
Prof. Dr. Giuseppe Lucarelli
Dr. Michele Battaglia
Prof. Dr. Ditonno Pasquale
Prof. Dr. Riccardo Schiavina
Prof. Dr. Ottavio De Cobelli
Dr. Gennaro Musi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- renal cell carcinoma
- biomarker
- molecular biology
- diagnosis
- prognosis
- pathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.